within Pharmacolibrary.Drugs.ATC.N;

model N02AC01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.4,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.0035,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.011666666666666665,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Dextromoramide is a strong synthetic opioid analgesic, structurally related to methadone, first developed in the 1950s for use in managing severe pain. It was widely used in some European countries but was later withdrawn in many regions due to its high abuse potential. As of today, dextromoramide is not in general clinical use or approved in most countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters in healthy adults. No reliable original published studies reporting compartmental pharmacokinetic details could be identified. Reported values are based on secondary sources and general opioid properties.</p><h4>References</h4><ol><li><p>Pagani, I, et al., &amp; Rovei, V (1989). Pharmacokinetics of dextromoramide in surgical patients. <i>Fundamental &amp; clinical pharmacology</i> 3(1) 27–35. DOI:<a href=&quot;https://doi.org/10.1111/j.1472-8206.1989.tb00027.x&quot;>10.1111/j.1472-8206.1989.tb00027.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2714730/&quot;>https://pubmed.ncbi.nlm.nih.gov/2714730</a></p></li><li><p>Gourlay, GK, et al., &amp; Plummer, JL (1997). Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain. <i>Pain</i> 69(3) 295–302. DOI:<a href=&quot;https://doi.org/10.1016/S0304-3959(96)03269-1&quot;>10.1016/S0304-3959(96)03269-1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9085304/&quot;>https://pubmed.ncbi.nlm.nih.gov/9085304</a></p></li><li><p>MacConnachie, AM (1998). Analgesics in the management of chronic pain. Part four: Step 3 oral analgesic drug therapy. <i>Intensive &amp; critical care nursing</i> 14(6) 318–319. DOI:<a href=&quot;https://doi.org/10.1016/s0964-3397(98)80693-9&quot;>10.1016/s0964-3397(98)80693-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10196915/&quot;>https://pubmed.ncbi.nlm.nih.gov/10196915</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N02AC01;
